Identifying a Serum Marker for Pancreatic Cancer
Author Information
Author(s): C.K. Ching, J.M. Rhodes
Primary Institution: University Department of Medicine and Walton Hospital, Liverpool, UK
Hypothesis
Can the peanut agglutinin binding glycoprotein be detected in normal or diseased pancreatic tissue?
Conclusion
The study found that a peanut lectin binding glycoprotein is present in both pancreatic cancer and normal pancreatic tissue.
Supporting Evidence
- A high molecular weight glycoprotein was found in 3 out of 3 pancreatic cancer samples.
- The glycoprotein had identical electrophoretic mobility to the serum marker.
- The study demonstrated the presence of the glycoprotein in both benign and malignant pancreatic tissues.
Takeaway
Researchers looked for a special protein in the pancreas that could help find pancreatic cancer, and they found it in both sick and healthy tissue.
Methodology
Pancreatic tissue samples were extracted and analyzed using SDS-PAGE and lectin blotting to identify glycoproteins.
Limitations
The study had a small sample size and did not include a diverse range of pancreatic diseases.
Participant Demographics
Patients included those with pancreatic cancer, chronic pancreatitis, and normal pancreatic tissue.
Want to read the original?
Access the complete publication on the publisher's website